{"id":1294,"date":"2022-09-15T11:53:39","date_gmt":"2022-09-15T11:53:39","guid":{"rendered":"https:\/\/vimizimhcp-dev-001.azurewebsites.net\/en-us\/vimizim\/?page_id=1294"},"modified":"2023-05-03T15:14:40","modified_gmt":"2023-05-03T15:14:40","slug":"key-patient-assessments","status":"publish","type":"page","link":"https:\/\/hcp.biomarin.com\/en-us\/vimizim\/key-patient-assessments\/","title":{"rendered":"Key Patient Assessments"},"content":{"rendered":"<div id=\"acf-block-643e73f735adb\" class=\"page-header\">         \n            \n        <div class=\"header-image\" style=\"background-image: url(https:\/\/hcp.biomarin.com\/en-us\/vimizim\/wp-content\/uploads\/sites\/2\/2022\/09\/Sherri.png?v=0.46)\"><\/div>\n     \n    <div class=\"header-content\">\n                    <h1>Assessments for the management of Morquio A<\/h1>\n            <\/div>\n<\/div>\n\n<div id=\"acf-block-643e73f735b28\" class=\"block wrapped-content\">\n    <div class=\"wrapper\">\n        <div class=\"inner-wrapper\">\n                \n<div id=\"acf-block-643e73f735d7f\" class=\"block-wysiwyg\">\n            <h2>Due to the heterogeneity of Morquio A, the 2019 management guidelines recommend developing individualized management plans<sup>1<\/sup><\/h2>\n    <\/div>\n        <\/div>\n    <\/div>\n<\/div>\n\n<div id=\"acf-block-643e73f735db9\" class=\"block split-content equal-bias content-align-top bottom-border\" data-muted-autoplay=\"false\">\n\t<div class=\"wrapper\">\n\t\t<div class=\"inner-wrapper\">\n\t\t                                                                <div class=\"content-block first-block\">\n                                                                                                <h3>To evaluate a patient\u2019s individual disease burden<sup>1<\/sup>:<\/h3>\n<ul>\n<li>Collect and document assessment information at treatment baseline<\/li>\n<li>Reevaluate assessments at follow-up visits<\/li>\n<\/ul>\n<p><strong>It is important to perform assessments before starting therapy in order to establish an individual management plan and develop realistic treatment expectations.<sup>1<\/sup><\/strong><\/p>\n                                                                                                                                                                                                                                                                                                                                                                                                                                                                        <p><a class=\"button button-download\" href=\"https:\/\/hcp.biomarin.com\/en-us\/vimizim\/vimizim-resources-and-support\/\" target=\"_self\">Download resources for your practice and your patients<\/a><\/p>\n                                                                                                                        <\/div>\n                    \n                                            <div class=\"content-block second-block\">\n                                                                                                                                                                                                                                                                                    \n                                    \n                                                                                                                \n                                    \n                                    <figure>\n                                        <div class=\"image image-rounded\">\n                                                                                            <img decoding=\"async\" class=\"\" src=\"https:\/\/hcp.biomarin.com\/en-us\/vimizim\/wp-content\/uploads\/sites\/2\/2022\/08\/Assessments-Chart.png?v=0.46\" alt=\"Assessments Chart\" \/>                                                                                    <\/div>\n                                                                            <\/figure>\n                                                                                    <\/div>\n                                                \t\t<\/div>\n\t<\/div>\n<\/div>\n\n<div id=\"acf-block-643e73f735de3\" class=\"block references\">\n    <div class=\"wrapper\">\n\t\t<div class=\"inner-wrapper\">\n\t\t    \t\t\t    <h4>References:\n<\/h4>\n\t\t\t\t\t\t                <ol>\n                                                                                                                        <li><span>Akyol MU, Alden TD, Amartino H, <em>et al.<\/em> Recommendations for the management of MPS IVA: systematic evidence- and consensus-based guidance. <em>Orphanet J Rare Dis<\/em>. 2019;14:137.\n<\/span><\/li>\n                                                            <\/ol>\n\t\t\t\t\t<\/div>\n\t<\/div>\n<\/div>","protected":false},"excerpt":{"rendered":"","protected":false},"author":2,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"class_list":["post-1294","page","type-page","status-publish","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>VIMIZIM\u00ae (elosulfase alfa) | Key Patient Assessments<\/title>\n<meta name=\"description\" content=\"Learn about important assessments for patients with Morquio A and recommendations for developing an individualized management plan. View boxed warning, including risk of anaphylaxis\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/hcp.biomarin.com\/en-us\/vimizim\/key-patient-assessments\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"VIMIZIM\u00ae (elosulfase alfa) | Key Patient Assessments\" \/>\n<meta property=\"og:description\" content=\"Learn about important assessments for patients with Morquio A and recommendations for developing an individualized management plan. View boxed warning, including risk of anaphylaxis\" \/>\n<meta property=\"og:url\" content=\"https:\/\/hcp.biomarin.com\/en-us\/vimizim\/key-patient-assessments\/\" \/>\n<meta property=\"og:site_name\" content=\"BioMarin Vimizim HCP EN-US\" \/>\n<meta property=\"article:modified_time\" content=\"2023-05-03T15:14:40+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/hcp.biomarin.com\\\/en-us\\\/vimizim\\\/key-patient-assessments\\\/\",\"url\":\"https:\\\/\\\/hcp.biomarin.com\\\/en-us\\\/vimizim\\\/key-patient-assessments\\\/\",\"name\":\"VIMIZIM\u00ae (elosulfase alfa) | Key Patient Assessments\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/hcp.biomarin.com\\\/en-us\\\/vimizim\\\/#website\"},\"datePublished\":\"2022-09-15T11:53:39+00:00\",\"dateModified\":\"2023-05-03T15:14:40+00:00\",\"description\":\"Learn about important assessments for patients with Morquio A and recommendations for developing an individualized management plan. View boxed warning, including risk of anaphylaxis\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/hcp.biomarin.com\\\/en-us\\\/vimizim\\\/key-patient-assessments\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/hcp.biomarin.com\\\/en-us\\\/vimizim\\\/key-patient-assessments\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/hcp.biomarin.com\\\/en-us\\\/vimizim\\\/key-patient-assessments\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/hcp.biomarin.com\\\/en-us\\\/vimizim\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Key Patient Assessments\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/hcp.biomarin.com\\\/en-us\\\/vimizim\\\/#website\",\"url\":\"https:\\\/\\\/hcp.biomarin.com\\\/en-us\\\/vimizim\\\/\",\"name\":\"BioMarin Vimizim HCP EN-US\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/hcp.biomarin.com\\\/en-us\\\/vimizim\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"VIMIZIM\u00ae (elosulfase alfa) | Key Patient Assessments","description":"Learn about important assessments for patients with Morquio A and recommendations for developing an individualized management plan. View boxed warning, including risk of anaphylaxis","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/hcp.biomarin.com\/en-us\/vimizim\/key-patient-assessments\/","og_locale":"en_US","og_type":"article","og_title":"VIMIZIM\u00ae (elosulfase alfa) | Key Patient Assessments","og_description":"Learn about important assessments for patients with Morquio A and recommendations for developing an individualized management plan. View boxed warning, including risk of anaphylaxis","og_url":"https:\/\/hcp.biomarin.com\/en-us\/vimizim\/key-patient-assessments\/","og_site_name":"BioMarin Vimizim HCP EN-US","article_modified_time":"2023-05-03T15:14:40+00:00","twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/hcp.biomarin.com\/en-us\/vimizim\/key-patient-assessments\/","url":"https:\/\/hcp.biomarin.com\/en-us\/vimizim\/key-patient-assessments\/","name":"VIMIZIM\u00ae (elosulfase alfa) | Key Patient Assessments","isPartOf":{"@id":"https:\/\/hcp.biomarin.com\/en-us\/vimizim\/#website"},"datePublished":"2022-09-15T11:53:39+00:00","dateModified":"2023-05-03T15:14:40+00:00","description":"Learn about important assessments for patients with Morquio A and recommendations for developing an individualized management plan. View boxed warning, including risk of anaphylaxis","breadcrumb":{"@id":"https:\/\/hcp.biomarin.com\/en-us\/vimizim\/key-patient-assessments\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/hcp.biomarin.com\/en-us\/vimizim\/key-patient-assessments\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/hcp.biomarin.com\/en-us\/vimizim\/key-patient-assessments\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/hcp.biomarin.com\/en-us\/vimizim\/"},{"@type":"ListItem","position":2,"name":"Key Patient Assessments"}]},{"@type":"WebSite","@id":"https:\/\/hcp.biomarin.com\/en-us\/vimizim\/#website","url":"https:\/\/hcp.biomarin.com\/en-us\/vimizim\/","name":"BioMarin Vimizim HCP EN-US","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/hcp.biomarin.com\/en-us\/vimizim\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/hcp.biomarin.com\/en-us\/vimizim\/wp-json\/wp\/v2\/pages\/1294","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/hcp.biomarin.com\/en-us\/vimizim\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/hcp.biomarin.com\/en-us\/vimizim\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/hcp.biomarin.com\/en-us\/vimizim\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/hcp.biomarin.com\/en-us\/vimizim\/wp-json\/wp\/v2\/comments?post=1294"}],"version-history":[{"count":24,"href":"https:\/\/hcp.biomarin.com\/en-us\/vimizim\/wp-json\/wp\/v2\/pages\/1294\/revisions"}],"predecessor-version":[{"id":2880,"href":"https:\/\/hcp.biomarin.com\/en-us\/vimizim\/wp-json\/wp\/v2\/pages\/1294\/revisions\/2880"}],"wp:attachment":[{"href":"https:\/\/hcp.biomarin.com\/en-us\/vimizim\/wp-json\/wp\/v2\/media?parent=1294"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}